Cambrex Corporation services

Cambrex provides a seamless method on-boarding process to establish robust methodology at our sites. We have extensive equipment capabilities that allow us to support full release and routine testing.

Cambrex has extensive experience in Drug Metabolism and Pharmacokinetic (DMPK), Bioanalytical and Biopharmaceutical Analyses. The Biopharmaceutical Analyses scope supports GMP method development, validation, and routine analysis including but not limited to host cell proteins, host cell DNAs, endotoxins, enzyme kinetics, and even bacteriophage titering assays. The Drug Metabolism and Pharmacokinetic (DMPK) scope supports pre-clinical discovery and development utilizing state-of-the-art instruments including High Resolution and LC-MS/MS. In addition, Cambrex has experience with metabolite identification (ID) from such studies.

Bioanalysis with an expert perspective: At Cambrex we’ve got the tools, insight and world-class expertise to support your demanding biopharmaceutical testing needs. We work closely with biotech start-ups and established biopharma companies to evaluate the quality, purity, safety and other key attributes of candidate viral therapies and large molecules at all phases of the preclinical and clinical development pipeline. We offer a comprehensive suite of testing services for complex biopharmaceutic products, including mammalian and bacterial viruses as well as other large molecules as well as monoclonal antibodies, RNA and DNA, enzymes, peptides, lipids and carbohydrates.

At Cambrex, we’re equipped to analyze raw materials to support pharmaceutical and medical device product development and manufacturing.